| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 01/28/2009 | CN101356156A Aspartic protease inhibitors |
| 01/28/2009 | CN101355951A Novel opioid antagonists |
| 01/28/2009 | CN101353327A Aryl substituted pyrimidine spirobifluorene derivative and preparation thereof |
| 01/28/2009 | CN100455580C Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 01/28/2009 | CN100455574C Thiazoline acid derivatives |
| 01/27/2009 | US7482490 2,7-Di(4,4,5,5-tetramethyl-1,3,2-dioxa-borolan-2-yl)-9,9'-bis(4-methoxymethyloxyphenyl)-9H-fluorene, for example; can be utilized as hole transport materials, hole injection materials or the like of organic electroluminescence devices, electrophotographic receptors |
| 01/27/2009 | US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis |
| 01/27/2009 | US7482466 Hydroxamates as therapeutic agents |
| 01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 01/27/2009 | US7482458 Quinoline derivatives |
| 01/27/2009 | US7482456 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors |
| 01/27/2009 | US7482374 Pyrrolidine-2-ones as Factor Xa inhibitors |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482370 Compounds for the treatment of inflammatory disorders |
| 01/27/2009 | US7482368 Triamide-substituted heterobicyclic compounds |
| 01/27/2009 | US7482366 Modulators of LXR |
| 01/27/2009 | US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 01/27/2009 | US7482347 CCR-3 receptor antagonists; inflammatory or allergic condition such as asthma or obstructive airway disease; 1-[1-(3,5-Dimethylisoxazole-4-sulfonyl)-piperdin-4-yl-methyl]-4-(4-fluorobenzyl)-piperazine; 1-(4-Fluorobenzyl)-4-(4-piperidinylmethyl) piperazine intermediate and a sulfonyl halide reactant |
| 01/27/2009 | US7482344 5-substituted arylmethylidenyl (thio)xanthenes; hypotensive agents, antiinflammatory agents, antiarthritic agents; congestive heart failure |
| 01/27/2009 | US7482335 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 01/27/2009 | CA2389280C Triazoles as farnesyl transferase inhibitors |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2206238C Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators |
| 01/22/2009 | WO2009012203A1 Processes and intermediates for the preparation of heterocyclic sulfonamide compounds |
| 01/22/2009 | WO2009011336A1 Quinoline compounds |
| 01/22/2009 | WO2009010761A1 Dna pk inhibitors |
| 01/22/2009 | WO2009010478A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 01/22/2009 | WO2009010477A1 Piperidine-4-acetic acid derivatives and their use |
| 01/22/2009 | WO2009010260A2 Condensed anthranilamide insecticides |
| 01/22/2009 | WO2008137809A3 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof |
| 01/22/2009 | WO2008130021A3 Heterocyclic hydrazide compound and pesticidal use of the same |
| 01/22/2009 | US20090023926 Biopolymer ionization; liquid chromatography |
| 01/22/2009 | US20090023917 Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms |
| 01/22/2009 | US20090023785 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/22/2009 | US20090023781 Haloalkyl Containing Compounds as Cysteine Protease Inhibitors |
| 01/22/2009 | US20090023763 Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists |
| 01/22/2009 | US20090023740 Sodium channel inhibitors |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/22/2009 | US20090023728 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparations Thereof and Uses Thereof |
| 01/22/2009 | US20090023710 Compound |
| 01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
| 01/22/2009 | US20090021149 Emitting Materials and Organic Light Emitting Device Using the Same |
| 01/22/2009 | US20090020732 Method of selectively separating carbon nanotubes, electrode comprising metallic carbon nanotubes separated by the method and oligomer dispersant for selectively separating carbon nanotubes |
| 01/22/2009 | CA2693926A1 Dna-pk inhibitors |
| 01/22/2009 | CA2690761A1 Benzimidazole poly(adp-ribose)polymerase inhibitors |
| 01/21/2009 | EP2017263A1 Heteroarylamide lower carboxylic acid derivative |
| 01/21/2009 | EP2016072A1 Factor xa inhibitors |
| 01/21/2009 | EP2016070A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016067A1 Insecticidal compounds |
| 01/21/2009 | EP2016057A1 C-fms kinase inhibitors |
| 01/21/2009 | EP1674460B1 Chromene compound |
| 01/21/2009 | EP1663983B1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 01/21/2009 | EP1613315B1 Quinoline-2-one-derivatives for the treatment of airways diseases |
| 01/21/2009 | EP1562939B1 Carboxamides |
| 01/21/2009 | EP1549655B1 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 01/21/2009 | EP1531816B1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
| 01/21/2009 | EP1517915B1 Prodrugs of excitatory amino acids |
| 01/21/2009 | EP1444211B1 Quinazoline derivatives as antitumor agents |
| 01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2009 | CN101351446A Novel fused pyrrole derivatives |
| 01/20/2009 | US7479562 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects of dry-mouth and constipation; biphenyl carbamate derivatives; biphenyl-2-ylcarbamic acid 1-(3-(3-[3-(4-hydroxybenzylamino)propyl]-2-oxoimidazolidin-1-yl)propyl)piperidin-4-yl ester |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479501 Heteroaryl-cyclic acetals |
| 01/20/2009 | US7479494 3-monosubstituted tropane derivatives as nociceptin receptor ligands |
| 01/20/2009 | US7479471 Applying to plants, seeds |
| 01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2372836C Substituted pyrrolidines as cell adhesion inhibitors |
| 01/20/2009 | CA2322204C 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents |
| 01/20/2009 | CA2293368C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 01/15/2009 | WO2009008000A2 A process for the preparation of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidino ethoxy) benzoyl]benzo[b]thiophene |
| 01/15/2009 | WO2009007747A2 Hydantoin derivatives used as mmp12 inhibitors |
| 01/15/2009 | WO2009007419A1 Novel bronchodilating isoquinoline carbamates |
| 01/15/2009 | WO2009007015A1 Malonamide derivatives with antithrombotic activity |
| 01/15/2009 | WO2008144222A3 Triazolyl aminopyrimidine compounds |
| 01/15/2009 | WO2008124083A3 Aurora kinase modulators and method of use |
| 01/15/2009 | US20090018177 Propane-1,3-Dione Derivative or Salt Thereof |
| 01/15/2009 | US20090018169 Sulfonamide Derivatives for the Treatment of Bacterial Infections |
| 01/15/2009 | US20090018168 administering 5-(3-((1R,2R,3R,5R)-5-chloro-2-((3,5-dichlorophenylthio)methyl)-3-hydroxycyclopentyl)propyl)-thiophene-2-carboxylic acid to reduce intraocular pressure; treating glaucoma |
| 01/15/2009 | US20090018150 5-Ht2b Receptor Antagonists |
| 01/15/2009 | US20090018149 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and methods for medical intervention against mycobacterial infections |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | CA2693396A1 Malonamide derivatives with antithrombotic activity |
| 01/14/2009 | EP2013178A1 Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists |
| 01/14/2009 | EP2013172A1 New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder |
| 01/14/2009 | EP2013170A1 4-squarylpiperazine derivatives as antiviral agents |
| 01/14/2009 | EP2012780A2 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors |
| 01/14/2009 | EP1751103B1 4-(5-(aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 01/14/2009 | EP1567518B1 Oxime ester photoinitiators with heteroaromatic groups |
| 01/14/2009 | EP1560584B1 Fab i inhibitors |
| 01/14/2009 | EP1532120B1 Phenylpyridazine derivatives as ligands for gaba receptors |
| 01/14/2009 | EP1477472B1 Substituted phenylalkanoic acid derivative and use thereof |
| 01/14/2009 | EP1323716B1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells |
| 01/14/2009 | EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 01/14/2009 | CN101346648A Photochromic materials having electron-withdrawing substituents |
| 01/14/2009 | CN101346369A Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 01/14/2009 | CN101346353A Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 01/14/2009 | CN101343251A Thrombopoietin mimetics |
| 01/14/2009 | CN101343250A Thrombopoietin mimetics |
| 01/14/2009 | CN101342169A Thrombopoietin mimetics |